The Safety and Efficacy of a Therapeutic Vaccine for Chronic Hepatitis B: A Follow-Up Study of Phase III Clinical Trial

被引:14
|
作者
Akbar, Sheikh Mohammad Fazle [1 ]
Al Mahtab, Mamun [2 ]
Aguilar, Julio Cesar [3 ]
Yoshida, Osamu [1 ]
Khan, Sakirul [4 ]
Penton, Eduardo [3 ]
Gerardo, Guillen Nieto [3 ]
Hiasa, Yoichi [1 ]
机构
[1] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon 7910295, Japan
[2] Bangabandhu Sheikh Mujib Med Univ BSMMU, Dept Hepatol, Dhaka 1000, Bangladesh
[3] Ctr Genet Engn & Biotechnol, Havana 10600, Cuba
[4] Oita Univ, Fac Med, Dept Microbiol, Oita 8795593, Japan
关键词
chronic hepatitis B; therapeutic vaccine; HBsAg; HBcAg vaccine; NASVAC; nasal vaccine; follow-up; CORE ANTIGEN; SURFACE; CANDIDATE; CELLS; HBCAG;
D O I
10.3390/vaccines10010045
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The objective of the present study was to assess the safety and efficacy of a therapeutic vaccine containing both HBsAg and HBcAg (NASVAC) in patients with chronic hepatitis B (CHB) three years after the end of treatment (EOT) as a follow-up of a phase III clinical trial. NASVAC was administered ten times by the nasal route and five times by subcutaneous injection. A total of 59 patients with CHB were enrolled. Adverse events were not seen in any of the patients. Out of the 59 CHB patients, 54 patients exhibited a reduction in HBV DNA, compared with their basal levels. Although all the patients had alanine transaminase (ALT) above the upper limit of normal (>42 IU/L) before the commencement of therapy, the levels of ALT were within the ULN level in 42 patients. No patient developed cirrhosis of the liver. The present study, showing the safety and efficacy of NASVAC 3 years after the EOT, is the first to report follow-up data of an immune therapeutic agent against CHB. NASVAC represents a unique drug against CHB that is safe, of finite duration, can be administered by the nasal route, is capable of reducing HBV DNA and normalizing ALT, and contains hepatic fibrosis.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Follow-up, Treatment and Non-invasive Scoring Systems in Chronic Hepatitis B: A Retrospective Observational Study
    Dogan, Ahmet
    Gezer, Yakup
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2023, 29 (01): : 22 - 29
  • [32] Efficacy and safety of therapeutic vaccines for the treatment of chronic hepatitis B: A systematic review and meta-analysis of randomized controlled trials update
    Geta, Mekuanint
    Mengistu, Getachew
    Yizengaw, Endalew
    Manyzewal, Tsegahun
    Hailu, Asrat
    Woldeamanuel, Yimtubeznash
    MEDICINE, 2024, 103 (35) : e39344
  • [33] Elecsys Hepatitis B Surface Antigen Quantitative Assay: Performance Evaluation and Correlation with Hepatitis B Virus DNA during 96 Weeks of Follow-up in Chronic Hepatitis B Patients
    Lee, Hyun Ji
    Kim, Shine Young
    Lee, Sun Min
    Heo, Jeong
    Kim, Hyung Hoi
    Chang, Chulhun L.
    Lee, Eun Yup
    Son, Han Chul
    ANNALS OF LABORATORY MEDICINE, 2012, 32 (06) : 420 - 425
  • [34] Failure of therapeutic vaccination using hepatitis B surface antigen vaccine in the immunotolerant phase of children with chronic hepatitis B infection
    Dikici, B
    Bosnak, M
    Ucmak, H
    Dagli, A
    Ece, A
    Haspolat, K
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2003, 18 (02) : 218 - 222
  • [35] Long-term follow-up of patients with chronic hepatitis B after interferon treatment
    Teuber, G
    Dienes, HP
    zumBuschenfelde, M
    Gerken, G
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1996, 34 (04): : 230 - 236
  • [36] THERAPEUTIC EFFECTS OF CLOZAPINE - 4-YEAR FOLLOW-UP OF A CONTROLLED CLINICAL-TRIAL
    LEON, CA
    ACTA PSYCHIATRICA SCANDINAVICA, 1979, 59 (05) : 471 - 480
  • [37] An Observational Study to Evaluate the Safety and Efficacy of Telbivudine in Adults with Chronic Hepatitis B
    Sulaiman, Ali
    Lesmana, Laurentius A.
    Nafrialdi
    Helyanna
    ACTA MEDICA INDONESIANA, 2014, 46 (01) : 38 - 43
  • [38] Significant changes in liver stiffness measurements in patients with chronic hepatitis B: 3-year follow-up study
    Fung, J.
    Lai, C. -L.
    Wong, D. K. -H.
    Seto, W. -K.
    Hung, I.
    Yuen, M. -F.
    JOURNAL OF VIRAL HEPATITIS, 2011, 18 (07) : E200 - E205
  • [39] Adherence to follow-up and treatment recommendations in Greek and immigrant patients with chronic hepatitis B in Greece
    Voulgaris, Theodoros
    Vlachogiannakos, John
    Ioannidou, Panagiota
    Papageorgiou, Maria-Vasiliki
    Zampeli, Evi
    Karagiannakis, Dimitrios
    Georgiou, Anastasia
    Papazoglou, Afroditi
    Karamanolis, George
    Papatheodoridis, George V.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (03) : 264 - 270
  • [40] Two-year follow-up study after treatment with lamivudine for chronic hepatitis B: seven cases reported
    Ide, T
    Kumashiro, R
    Suzuki, H
    Tanikawa, K
    Sata, M
    HEPATOLOGY RESEARCH, 2000, 17 (03) : 197 - 204